
|Articles|July 1, 2005
- Volume 0 0
Sleepiness During Meetings
Advertisement
Are you curious as to why individuals fall asleep at business meetings? Boredom may notbe the reason. A survey of 1000 professionals showed that 25% of them admitted to fallingasleep in a meeting because of sleep deprivation, and 70% thought that they were less productiveafter traveling. Of the survey respondents, almost 1 in 5 had a presentation go badlyor lost business because of poor sleep due to air travel. British Airways and Research Internationalconducted the survey during the recent National Sleep Awareness Week.
Articles in this issue
over 21 years ago
Antibiotics, Probiotics, and Microfloraover 21 years ago
Calcium: An Essential Mineralover 21 years ago
CAN YOU READTHESE Rxs?over 21 years ago
ECKEL RECEIVES ALUMNI AWARDover 21 years ago
Cancer: Update on Biologicsover 21 years ago
Managing Chronic Pain: An Analysis of the Use of Opioidsover 21 years ago
PHARMACIST'S RIGHT TO CHOOSE?over 21 years ago
Teenage Drug Diversion—Part 2over 21 years ago
Is Altering Refills a Criminal Act?over 21 years ago
Do All SSRIs Interact the Same Way?Advertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Prescription Volume: Measuring the Pharmacist’s Value
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
4
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
5


